Resveratrol And Fertility | Excerpt from Resveratrol Health Series

Except from Dr. Erica Nikiforuk’s article in Naturopathic Currents in January 2014, you can read the original article here.

This article has been broken down into a four part series, and links to the other parts of this series will be listed below as published.

Resveratrol and Fertility

So far, we have described the basis for resveratrol as an antiaging compound. As is well known, fertility declines with age, and it seems that this process can be sped up by the presence of oxidative damage. Therefore, as it relates to fertility, resveratrol may have a role in preserving fertility, protecting immature egg cells or oocytes, and potentially extending the fertile years.

The decline in female fertility begins in a woman’s early 30s. In fact, a woman’s chronological age is often cited as the single most important factor in predicting the reproductive potential of a couple. A woman’s age will impact both the quantity of oocytes (immature eggs waiting to be released) as well as the quality of the eggs.[4] While assisted reproductive technologies (ART) such as in vitro fertilization (IVF) can often increase the number of eggs available to fertilize through induction of “superovulation,” few interventions exist which can favorably impact the quality of the eggs.[4] As such, poor egg quality often hinders a couple’s ability to conceive.

Each woman is born already possessing all of her egg cells; they are located in each of her ovaries, and are arrested in middevelopment at birth. For 10 to 15 years until puberty, these immature eggs will remain quiescent, until a hormonal cascade signals their growth, ovulation, or atresia (normal breakdown process). During this prolonged wait period, the immature eggs are susceptible to damage caused by free-radical accumulation.[4] Damage to mitochondria, telomerase, and mutations in the DNA affect egg quality and a woman’s chances of conceiving, as they hinder the ability of the egg to survive and grow.[4] As described earlier, resveratrol plays a role in protecting cells from oxidative damage by activating antiaging genes, protecting mitochondrial function, and enhancing telomerase activity.[4] Several animal studies have highlighted the potential ability of resveratrol to favorably impact both egg quality and quantity.

A 2013 study was carried out in mice to assess whether resveratrol could protect oocytes from damage caused by free radicals. Given the plausible mechanism, the researchers wondered whether resveratrol could maintain oocyte quality over time, thus prolonging the reproductive years.[4] The results were very impressive and provided evidence of a fertility-sparing effect of resveratrol in the female mouse. Mice who had been given resveratrol maintained a larger follicle pool than their age-matched controls.

Furthermore, telomerase activity, and gene expression in the ovaries of the mice receiving resveratrol resembled that of younger mice, indicating resveratrol was able to slow was able to slow the aging process in the ovaries and preserve oocyte quality.[4] A second animal study showed similar results, with resveratrol-treated animals maintaining a greater number of oocytes in the follicular pool.[12] Thus, both of these studies demonstrated that treatment with resveratrol is able to favorably impact both the quality and the quantity of oocytes and extend reproductive life span in rodents.[4, 12] It should be noted that although these results seem very promising, there is a need to confirm these effects in humans, as the applicability to extending the human reproductive period remains to be determined.[4]

A second common condition affecting fertility is polycystic ovary syndrome (PCOS). A newly published study assessed whether resveratrol could pact the follicles of women suffering from PCOS or obesity-related infertility who were undergoing IVF. In women with obesity and/or PCOS, elevated levels of oxidative stress are proposed as a major contributing factor to infertility. For instance, these women have elevated levels of oxidized LDL cholesterol (i.e. damaged LDL), which circulates through the body and subsequently damages various cells and tissues. In the ovary, high levels of oxidized LDL damage developing follicles, which can reduce the chances of ovulation. In fact, in these women, levels of oxidized LDL were approximately double and were found to correlate negatively with the success of IVF outcomes.[13]

The study went on to evaluate whether resveratrol could protect the granulosa cells (the cells which surround and nourish the oocyte) from the damaging effects of oxidized LDL. In the presence of oxidized LDL, the follicle was less likely to survive. However, when the granulosa cells were exposed to resveratrol, markers of oxidative stress were significantly reduced, and the cells were better able to survive.[13] As a whole, the study highlights a potential role for resveratrol in reducing oxidative stress in the ovary, thereby improving fertility outcomes for women who suffer from infertility related to PCOS or obesity.[13] Future human trials may help to more fully understand the extent of benefits and possible transgenerational effects of the use of resveratrol to improve fertility outcomes.[13]

References

  1. Bishayee, A.. “Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials”. Cancer Prevention Research Vol. 2, No. 5 (2009): 409–418.
  2. Raederstorff, D., I. Kunz, and J. Schwager. “Resveratrol, from experimental data to nutritional evidence: the emergence of a new food ingredient”. Annals of the New York Academy of Sciences Vol. 1290 (2013): 136–141.
  3. Bai, T., D.S. Dong, and L. Pei. “Resveratrol mitigates isoflurane-induced neuroapoptosis by inhibiting the activation of the Akt-regulated mitochondrial apoptotic signaling pathway”. International Journal of Molecular Medicine Vol. 32, No. 4 (2013): 819–826.
  4. Liu, M., et al. “Resveratrol protects against age-associated infertility in mice”. Human Reproduction Vol. 28, No. 3 (2013): 707–717.
  5. Olesen, J., et al. “Role of PGC-1α in exercise training- and resveratrol-induced prevention of age-associated inflammation”. Experimental Gerontology Vol. 48, No. 11 (2013): 1274–1284.
  6. Das, DK., S. Mukherjee, and D. Ray. “Erratum to: Resveratrol and red wine, healthy heart and longevity”. Heart Failure Reviews Vol. 16, No. 4 (2011): 425–435.
  7. Barger, J.L., et al. “A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice”. PLoS One Vol. 3, No. 6 (2008): e2264.
  8. Mobasheri, A. and M. Shakibaei. “Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis”. Annals of the New York Academy of Sciences Vol. 1290 (2013): 59–66.
  9. Wong, R.H., et al. “Evidence for circulatory benefits of resveratrol in humans”. Annals of the New York Academy of Sciences Vol. 1290 (2013): 52–58.
  10. Zhao, H., et al. “Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus”. The British Journal of Nutrition 2013 Sep 30: 1–11. [Epub ahead of print]
  11. Matin, S.L., T.M. Hardy, and T.O. Tollefsbol. “Medicinal chemistry of the epigenetic diet and caloric restriction”. Current Medicinal Chemistry Vol. 20, No. 32 (2013): 4050–4059.
  12. Kong, X.X., et al. “Resveratrol, an effective regulator of ovarian development and oocyte apoptosis”. Journal of Endocrinological Investigation Vol. 34, No. 11 (2011): e374–e381.
  13. Baek, S.H., et al. “Creation of resveratrol-enriched rice for the treatment of metabolic syndrome and related diseases”. PLoS One Vol. 8, No. 3 (2013): e57930.
  14. Pérez-Torres, I., et al. “Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome”. Cardiovascular & Hematological Agents in Medicinal Chemistry Vol. 11, No. 1 (2013): 25–37.
  15. Bhatt, J.K., S. Thomas, and M.J. Nanjan. “Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus”. Nutrition Research Vol. 32, No. 7 (2012): 537–541.
  16. Pearson, K.J., et al. “Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span”. Cell Metabolism Vol. 8, No. 2 (2008): 157–168.
  17. Militaru, C., et al. “Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life”. Nutrition Vol. 29, No. 1 (2013): 178–183.
  18. Bo, S., et al. “Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial”. Current Medicinal Chemistry Vol. 20, No. 10 (2013): 1323–1331.
  19. Poulsen, M.M., et al. “High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition”. Diabetes Vol. 62, No. 4 (2013): 1186–1195.
  20. Gliemann, L., et al. “Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men”. The Journal of Physiology Vol. 591, No. 20 (2013): 5047–5059.
  21. Smoliga, J.M., E.S. Colombo, and M.J. Campen. “A healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations”. Aging (Albany NY) Vol. 5, No. 7 (2013): 495–506.
  22. Qiao, H., et al. “Antitumor effects of naturally occurring oligomeric resveratrol derivatives”. FASEB Journal Vol. 27, No. 11 (2013): 4561–4571.
  23. Temraz, S., D. Mukherji, and A. Shamseddine. “Potential targets for colorectal cancer prevention”. International Journal of Molecular Sciences Vol. 14, No. 9 (2013): 17279–17303.
  24. Gescher, A., W.P. Steward, and K. Brown. “Resveratrol in the management of human cancer: how strong is the clinical evidence?” Annals of the New York Academy of Sciences Vol. 1290 (2013): 12–20.
  25. Kumazaki, M., et al. “Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells”. The Journal of Nutritional Biochemistry Vol. 24, No. 11 (2013): 1849–1858.
  26. Patel, K.R., et al. “Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients”. Cancer Research Vol. 70, No. 19 (2010): 7392–7399.

Are you in Ontario, Canada seeking treatment?